FIELD: medicine.
SUBSTANCE: invention refers to medicine, particularly to experimental pharmacology, and can be used for correction of acute pancreatitis in rats using montmorillonite-based enterosorbent. That is ensured by simulating acute pancreatitis by intraperitoneal single administration of a solution of L-arginine in a phosphate buffer pH = 6.8 in dose of 1.5 g/kg. That is followed by correcting acute pancreatitis by intragastric introduction of an enterosorbent based on montmorillonite. Montmorillonite-based enterosorbent is activated with hydrochloric acid and contains montmorillonite 62.1 wt%; silver 0.11 wt%; organic additives: dextrose, vanillin, saccharine 37.79 wt%.
EFFECT: invention reduces blood serum amylase activity.
1 cl, 2 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| ENTHEROSORBENT | 2006 |
|
RU2319488C1 |
| AGENT WITH PANCREAS AND HEPATOPROTECTIVE ACTIVITY FOR PARENTERAL ADMINISTRATION | 2017 |
|
RU2662324C1 |
| ORAL PHARMACEUTICAL COMPOSITION FOR TREATING INFLAMMATORY GASTROINTESTINAL DISEASES | 2010 |
|
RU2445965C2 |
| PREPARATION POSSESSING ADSORPTIVE AND DETOXIFYING ACTIVITY | 2013 |
|
RU2561038C2 |
| METHOD FOR CORRECTION OF PLACENTAL MICROCIRCULATION DISORDER BY ARGINASE II INHIBITOR | 2016 |
|
RU2644271C1 |
| METHOD FOR PREVENTING RENAL DYSFUNCTION WITH AN ARGINASE II INHIBITOR IN EXPERIMENT | 2018 |
|
RU2696580C1 |
| METHOD FOR TREATING ACUTE PANCREATITIS | 2000 |
|
RU2198680C2 |
| METHOD FOR CORRECTION OF ISONIAZID-INDUCED HEPATOTOXIC REACTIONS | 2015 |
|
RU2601919C1 |
| COMPOSITION POSSESSING ENDOTHELIAL PROTECTIVE, VASODILATING AND ANGIOPROTECTIVE EFFECT | 2011 |
|
RU2464019C1 |
| METHOD FOR SIMULATING CHRONIC HEPATITIS | 2013 |
|
RU2541824C1 |
